了解雄激素受体结构和功能以及开发下一代AR向治疗的进展
Wendy Effah1, Marjana Khalil1, Dong-Jin Hwang2
1Department of Medicine, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
雄激素受体 (AR) 对组织发育和疾病至关重要,最近的进展突出了其治疗潜力. 新的AR向分子正在出现,用于诸如前列腺癌等疾病.
科学领域:
- 内分泌学和分子生物学
- 受体 (AR) 信号传递的分子机制.
背景情况:
- 雄激素受体 (AR) 和其连接体对于正常的生理过程至关重要.
- 对AR信号的失调有助于各种疾病,使其成为关键的治疗点.
- 包括agonists和antagonists在内的AR配体是治疗前列腺癌和阴性腺症等疾病的既定治疗方法.
研究的目的:
- 提供关于AR生物学近期进展的全面概述.
- 阐明AR作用背后的分子机制.
- 审查目前正在开发的用于临床应用的新型AR向分子.
主要方法:
- 最近关于雄激素受体 (AR) 生物学研究的文献综述.
- 对AR作用的分子机制的分析.
- 在临床前和临床开发中对下一代AR向分子的调查.
主要成果:
- 在过去的十年中,在了解AR生物学及其在疾病中的作用方面取得了重大进展.
- 对AR功能的新分子洞察力正在出现,为新的治疗策略提供了潜力.
- 一些有前途的下一代AR向分子正在开发中,有可能产生重大临床影响.
结论:
- 最近AR生物学和分子机制的突破为令人兴奋的治疗机会提供了机会.
- 新型AR向剂的开发有望改善AR依赖性疾病的治疗.
- 预计未来十年的持续研究将进一步澄清这些发展,并巩固AR在药物发现中的作用.
更多相关视频
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
相关概念视频
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targeted Cancer Therapies
There are several types of targeted therapies against...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Mitogens and the Cell Cycle
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
